How the ‘Experts’ Got Tariffs So Wrong—and Trump Got It Right
Trump has a new idea about the economy. The usual suspects hate it. On June 13, Trump said he’d consider a 10 percent tariff on imports and use the revenue to reduce some income taxes.
CPA’s Jeff Ferry: An Economist’s Wish List On The Trump/Biden Debate
When asked about China, both Trump and Biden should say that China’s trade surplus is an insult to the world and a huge disruptor to our economy.
CPA Supports Sen. Rick Scott’s Trio of China Stocks Legislation
The CCP’s weaponization of U.S. capital markets and American retail investors to fund its malign activities is only possible because of Wall Street firms’ fiduciary malfeasance and complicity.
CPA Chairman: Get China Out of America’s Military Supply Chain
Chinese companies supply many inputs for America’s military, putting the U.S. in a disturbingly vulnerable position. This threatens the survival of the small domestic manufacturers that play a critical role in America’s defense industrial base.
CPA Chief Economist Jeff Ferry Talks Tariffs, Taxes & The Dollar In Industry Week Webinar
CPA’s chief economist Jeff Ferry joined two other panelists Wednesday to talk trade in an hour-long webinar by Industry Week magazine titled the “2024 Manufacturing Economy First Half Checkup.”
Ohio’s Solar Manufacturers Deserve a Level Playing Field
China is flooding the global market with solar panels. It’s part of an aggressive strategy by Beijing to dominate the world’s solar industry.
John Deere: Shrinking In Iowa, But Set To Grow In Mexico
John Deere will lay off or offer early retirement to over 200 workers in Iowa, while at the same time the tractor producer is gearing up to move production of mid-frame skid steer loaders and compact loaders from its plant in Dubuque, Iowa to a proposed new facility in Mexico.
North Carolina is Helping China Enter the US Solar Panel Market. That’s a Mistake.
The U.S. solar manufacturing industry can play an important role in the 21st century economy. But that requires a smart, coherent trade and industrial strategy to counter China.
How to Address America’s Historic Drug Shortage Crisis
The United States is facing an unprecedented drug shortage, with a record 323 active drug shortages at the start of 2024 — the highest number since 2001.
Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls
The foreign labs in China and India that make the branded drugs for CVS pharmacies nationwide are coming under increased scrutiny for unsafe manufacturing practices.
